Perspective TherapeuticsCATX
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$3.19avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Perspective Therapeutics Inc. (CATX) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was Portland Investment Counsel Inc. ($479K).
- Company
- Perspective Therapeutics Inc.
- CUSIP
- 46489V104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 79,999 shares bought, net +79,999 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Portland Investment Counsel Inc. | 0.12% | Add +114.3% | 150,000 | $479K |
"% of holder's portfolio" is CATX's weight in each manager's 13F, not the share of Perspective Therapeutics Inc. the manager owns.